Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05704517Recruiting

Progressive Familial Intrahepatic Cholestasis in Indian Children - Establishing an Indian PFIC Registry

Role: collaborator

NCT04899076Completed

Stool Processing Kit (SPK) Evaluation for Pediatric Tuberculosis (TB)

Role: collaborator

NCT04851808Unknown

Chronic Respiratory Disease Burden in Bangladesh

Role: collaborator

NCT03876249Unknown

The Long-term Effect of RSV Infection

Role: collaborator

All 4 trials loaded